bioMerieux SA.:企業の戦略・SWOT・財務分析

◆英語タイトル:bioMerieux SA. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4752
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

bioMerieux SA. – Strategy, SWOT and Corporate Finance Report
Summary

bioMerieux SA. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

bioMerieux SA (bioMerieux or ‘the company’), is a provider of diagnostic solutions for medical and industrial applications. These products are used to diagnose cardiovascular diseases, targeted cancers and infectious diseases and provides various vitro diagnostic solutions for hospitals. It also offers sterility and quality testings for cosmetics, pharmaceutical and food sectors. It has operations across Europe, the Middle East and Africa (EMEA), the Americas and Asia Pacific. The company is headquartered in Marcy l’Etoile, France.

Scope

- Detailed information on bioMerieux SA. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting bioMerieux SA. in the form of a SWOT analysis
- An in-depth view of the business model of bioMerieux SA. including a breakdown and examination of key business segments
- Intelligence on bioMerieux SA.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about bioMerieux SA., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of bioMerieux SA. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess bioMerieux SA. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on bioMerieux SA.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
bioMerieux SA.: Company Overview
bioMerieux SA.: Overview and Key Facts
bioMerieux SA.: Overview
bioMerieux SA.: Key Facts
bioMerieux SA.: Key Employees
bioMerieux SA.: Key Employee Biographies
bioMerieux SA.: Major Products and Services
bioMerieux SA.: Company History
bioMerieux SA.: Management Statement
bioMerieux SA.: Locations and Subsidiaries
bioMerieux SA.: Key Competitors
bioMerieux SA.: Company Analysis
bioMerieux SA.: Business Description
bioMerieux SA.: SWOT Analysis
bioMerieux SA.: SWOT Overview
bioMerieux SA.: Strengths
bioMerieux SA.: Weaknesses
bioMerieux SA.: Opportunities
bioMerieux SA.: Threats
bioMerieux SA.: Corporate Financial Deals Activity
bioMerieux SA.: Financial Deals Overview
bioMerieux SA.: Targets and Partners
bioMerieux SA.: Top Deals 2016 – 2020YTD*
bioMerieux SA.: Advisors
bioMerieux SA.: Top Legal Advisors
bioMerieux SA.: Mergers and Acquisitions
bioMerieux SA.: Corporate Venturing
bioMerieux SA.: Partnership
bioMerieux SA.: Recent Developments
bioMerieux SA.: News and Events Summary
bioMerieux SA.: Business Expansion
bioMerieux SA.: Financial Performance
bioMerieux SA.: Market Developments
bioMerieux SA.: Regulatory and Legal Events
bioMerieux SA.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: bioMerieux SA.: Key Facts
Table 2: bioMerieux SA.: Key Employees
Table 3: bioMerieux SA.: Company History
Table 4: bioMerieux SA.: Locations and Subsidiaries
Table 5: bioMerieux SA.: Key Competitors
Table 6: bioMerieux SA.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: bioMerieux SA.: M&A Activity by Geography (TTM*)
Table 8: bioMerieux SA.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: bioMerieux SA.: M&A Average Deal Size - Value (US$m)
Table 10: bioMerieux SA.: Targets and Partners
Table 11: bioMerieux SA.: Top Deals 2016 - 2020YTD*
Table 12: bioMerieux SA.: Legal Advisor Ranking by Value (US$m)
Table 13: bioMerieux SA.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: bioMerieux SA.: M&A Activity by Geography (2016 - YTD*2020)
Table 15: bioMerieux SA.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 16: bioMerieux SA.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 17: bioMerieux SA.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: bioMerieux SA.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: bioMerieux SA.: News and Events Summary
Table 20: bioMerieux SA.: Business Expansion
Table 21: bioMerieux SA.: Financial Performance
Table 22: bioMerieux SA.: Market Developments
Table 23: bioMerieux SA.: Regulatory and Legal Events
Table 24: bioMerieux SA.: Strategy and Operations

★海外企業調査レポート[bioMerieux SA.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Corp (8053):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務情報
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pierrel Spa (PRL):企業の財務・戦略的SWOT分析
    Pierrel Spa (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kiniksa Pharmaceuticals Ltd (KNSA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kiniksa Pharmaceuticals Ltd (Kiniksa Pharmaceuticals) is a clinical-stage biopharmaceutical company focused on discovery, acquisition, development and commercialization of therapeutic medicines for the treatment of auto inflammatory and autoimmune diseases. Its pipeline product portfolio inc …
  • Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option fo …
  • AGL Energy Ltd:発電所・企業SWOT分析
    AGL Energy Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Pacific Hydro Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Pacific Hydro Pty Ltd (Pacific Hydro), a subsidiary of State Power Investment Corporation is an energy solutions provider that undertakes the development and operations of the renewable power projects. The company offers wind, hydro, solar and geothermal power projects at varying stages of d …
  • Mamee-Double Decker (M) Berhad:企業の戦略的SWOT分析
    Mamee-Double Decker (M) Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ContraFect Corp (CFRX):製薬・医療:M&Aディール及び事業提携情報
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • Humabs BioMed SA-製薬・医療分野:企業M&A・提携分析
    Summary Humabs BioMed SA (Humabs) is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company’s pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develops cellclone technologies, a proprietary …
  • Samsung Fire & Marine Insurance Co., Ltd.:企業の戦略・SWOT・財務情報
    Samsung Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Newrest Group International S.A.S:企業の戦略・SWOT・財務情報
    Newrest Group International S.A.S - Strategy, SWOT and Corporate Finance Report Summary Newrest Group International S.A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Euronav NV (EURN):石油・ガス:M&Aディール及び事業提携情報
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides sea-borne transportation, tanker shipping, proactive management, fleet composition and ship management services, among others. It offers ship management services which includes …
  • Irving Oil Ltd:企業の戦略的SWOT分析
    Irving Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kerecis ehf:製品パイプライン分析
    Summary Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura m …
  • Graybug Vision Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Graybug Vision Inc (Graybug Vision) is a clinical stage pharmaceutical company that develops next generation products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company’s lead candidate include GB-102, a clinical-stage depot formulation of sun …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆